Stewart J D, Roberts V A, Thomas N R, Getzoff E D, Benkovic S J
Department of Chemistry, 152 Davey Laboratory, Pennsylvania State University 16802.
Biochemistry. 1994 Mar 1;33(8):1994-2003. doi: 10.1021/bi00174a004.
Individual residues important for ligand binding and catalytic activity were identified by computer modeling and investigated by site-directed mutagenesis for catalytic antibody 43C9, which accelerates amide hydrolysis by a factor of 10(6). On the basis of a computer model, Tyr L32, His L91, Arg L96, His H35, and Tyr H95 were chosen for replacement by site-directed mutagenesis. To facilitate these studies, an expression system was developed in which properly folded 43C9 single-chain antibody was secreted from an engineered Escherichia coli host. Substitution of His L91 by Gln produced a mutant with no catalytic activity, but whose affinities for ligands were nearly the same as those of the wild-type, identifying His L91 as the nucleophile that forms the acyl intermediate implicated by previous kinetic studies. Arg L96 is also critical for catalytic activity and appears to function as a oxyanion hole for the tetrahedral transition states. Two substitutions for His H35 resulted in mutant proteins with no catalytic activity as well as altered affinities for ligands, indicating an important structural role for this residue. Substitutions for Tyr L32 and Tyr H95 were made in an attempt to improve the catalytic efficiency of 43C9. The results of these mutations allow us to propose a mechanism for 43C9-catalyzed hydrolysis: Substrate binding to 43C9 orients the scissile carbonyl group adjacent to both the His L91 and Arg L96 side chains. The imidazole of His L91 acts as a nucleophile, forming an acyl-antibody intermediate that breaks down by hydroxide attack to afford the products and regenerate the catalyst.
通过计算机建模确定了对配体结合和催化活性重要的个别残基,并通过定点突变对催化抗体43C9进行了研究,该抗体可使酰胺水解加速10^6倍。基于计算机模型,选择Tyr L32、His L91、Arg L96、His H35和Tyr H95进行定点突变替换。为便于这些研究,开发了一种表达系统,其中经工程改造的大肠杆菌宿主可分泌正确折叠的43C9单链抗体。用Gln替换His L91产生了一个无催化活性的突变体,但其对配体的亲和力与野生型几乎相同,这表明His L91是形成先前动力学研究所涉及的酰基中间体的亲核试剂。Arg L96对催化活性也至关重要,似乎作为四面体过渡态的氧负离子洞发挥作用。His H35的两个替换导致突变蛋白无催化活性以及对配体的亲和力改变,表明该残基具有重要的结构作用。对Tyr L32和Tyr H95进行替换以试图提高43C9的催化效率。这些突变结果使我们能够提出43C9催化水解的机制:底物与43C9结合使可裂解羰基与His L91和Arg L96侧链相邻排列。His L91的咪唑作为亲核试剂,形成酰基 - 抗体中间体,该中间体通过氢氧根攻击分解以产生产物并使催化剂再生。